These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25087053)

  • 21. Population need and geographical access to general practitioners in rural New Zealand.
    Brabyn L; Barnett R
    N Z Med J; 2004 Aug; 117(1199):U996. PubMed ID: 15475979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community pharmacists: a forgotten resource for palliative care.
    Tait PA; Gray J; Hakendorf P; Morris B; Currow DC; Rowett DS
    BMJ Support Palliat Care; 2013 Dec; 3(4):436-43. PubMed ID: 24950524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Pharmacy deserts' are prevalent in Chicago's predominantly minority communities, raising medication access concerns.
    Qato DM; Daviglus ML; Wilder J; Lee T; Qato D; Lambert B
    Health Aff (Millwood); 2014 Nov; 33(11):1958-65. PubMed ID: 25367990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Availability of emergency contraception at rural and urban pharmacies in Pennsylvania.
    Chuang CH; Shank LD
    Contraception; 2006 Apr; 73(4):382-5. PubMed ID: 16531172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries.
    Vogler S; Habimana K; Arts D
    Health Policy; 2014 Sep; 117(3):311-27. PubMed ID: 24962537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The geographic accessibility of pharmacies in Nova Scotia.
    Law MR; Heard D; Fisher J; Douillard J; Muzika G; Sketris IS
    Can Pharm J (Ott); 2013 Jan; 146(1):39-46. PubMed ID: 23795168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capturing data on medicines usage: the potential of community pharmacy databases.
    Ryan K; Norris P; Becket G
    N Z Med J; 2005 Oct; 118(1223):U1677. PubMed ID: 16224501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equity in the distribution of community pharmacies in England: impact of regulatory reform.
    Wagner A; Hann M; Noyce P; Ashcroft D
    J Health Serv Res Policy; 2009 Oct; 14(4):243-8. PubMed ID: 19770123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergency contraception availability in New Mexico: impact of direct pharmacy access.
    Ogburn JA; Espey E; Benjamin A
    J Am Pharm Assoc (2003); 2008; 48(3):388-92. PubMed ID: 18595824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future economic outlook of Nebraska rural community pharmacies based on break-even analysis of community operational costs and county population.
    Keast SL; Jacobs E; Harrison D; Farmer K; Thompson D
    Res Social Adm Pharm; 2010 Sep; 6(3):209-20. PubMed ID: 20813334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of regulation of Community Pharmacies on efficiency, access and equity. Evidence from the UK and Spain.
    Lluch M; Kanavos P
    Health Policy; 2010 May; 95(2-3):245-54. PubMed ID: 20056292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
    Rudholm N
    Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in community pharmacy counts and closures before and after the implementation of Medicare part D.
    Klepser DG; Xu L; Ullrich F; Mueller KJ
    J Rural Health; 2011; 27(2):168-75. PubMed ID: 21457309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Market dynamics of community pharmacies in Minnesota.
    Schommer JC; Singh RL; Cline RR; Hadsall RS
    Res Social Adm Pharm; 2006 Sep; 2(3):347-58. PubMed ID: 17138519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competition among pharmacies and the typology of services delivered: The Portuguese case.
    Martins L; Queirós S
    Health Policy; 2015 May; 119(5):640-7. PubMed ID: 25812747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacy characteristics associated with the provision of drug therapy services in nonmetropolitan community pharmacies.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Rural Health; 2009; 25(3):290-5. PubMed ID: 19566615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update: Independently Owned Pharmacy Closures in Rural America, 2003-2018.
    Salako A; Ullrich F; Mueller KJ
    Rural Policy Brief; 2018 Jul; 2018(2):1-6. PubMed ID: 30080364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should community-managed drug stores be phased out?
    Flores FP; Umenai T; Wakai S
    Asia Pac J Public Health; 2001; 13(1):9-12. PubMed ID: 12109264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health care policy and community pharmacy: implications for the New Zealand primary health care sector.
    Scahill S; Harrison J; Carswell P; Shaw J
    N Z Med J; 2010 Jun; 123(1317):41-51. PubMed ID: 20657630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.